2019
2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime
Rathod S, McManus D, Rivera-Vinas J, Topal J, Martinello R. 2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime. Open Forum Infectious Diseases 2019, 6: s823-s824. PMCID: PMC6810941, DOI: 10.1093/ofid/ofz360.2063.Peer-Reviewed Original ResearchPiperacillin/tazobactamClostridioides difficile infectionMultivariate logistic regression modelCDI riskHealthcare-Associated InfectionsPTZ exposureLogistic regression modelsHospital admissionDifficile infectionΒ-lactam/β-lactamase inhibitorsCharlson Comorbidity Index scoreCommon healthcare-associated infectionsYale-New Haven HospitalComorbidity Index scoreAntibiotic stewardship effortsObservational cohort studyAntibiotic-associated diarrheaNew Haven HospitalFrequency of testingAnti-pseudomonal cephalosporinsCephalosporin therapyCohort studyΒ-lactamase inhibitorsAntibiotic therapySuppression therapy
2018
492. Long-Term Outcomes of Clostridium difficile Infection Among Medicare Beneficiaries
Hatfield K, Baggs J, Winston L, Parker E, Martin B, Meek J, Olson D, Farley M, Revis A, Holzbauer S, Bye M, Wilson L, Perlmutter R, Phipps E, Pierce R, Ocampo V, Kainer M, Smith M, McDonald L, Jernigan J, Guh A. 492. Long-Term Outcomes of Clostridium difficile Infection Among Medicare Beneficiaries. Open Forum Infectious Diseases 2018, 5: s182-s182. PMCID: PMC6253260, DOI: 10.1093/ofid/ofy210.501.Peer-Reviewed Original ResearchClostridium difficile infectionEmerging Infections ProgramDifficile infectionInclusion criteriaCommon healthcare-associated infectionsPrevention's Emerging Infections ProgramMultivariable logistic regression modelICD-9-CM codesOlder adultsDifficile stool testMedicaid Services beneficiariesNumber of hospitalizationsHealthcare-Associated InfectionsSkilled nursing facilitiesLong-term riskLogistic regression modelsSame catchment areaExcess morbidityHospitalization statusStool testPoor outcomeTerm outcomesAdjusted oddsCDI casesChronic conditionsRisk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort Study
Kamboj M, Childers T, Sugalski J, Antonelli D, Bingener-Casey J, Cannon J, Cluff K, Davis KA, Dellinger EP, Dowdy SC, Duncan K, Fedderson J, Glasgow R, Hall B, Hirsch M, Hutter M, Kimbro L, Kuvshinoff B, Makary M, Morris M, Nehring S, Ramamoorthy S, Scott R, Sovel M, Strong V, Webster A, Wick E, Aguilar JG, Carlson R, Sepkowitz K. Risk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort Study. Infection Control And Hospital Epidemiology 2018, 39: 555-562. PMID: 29553001, PMCID: PMC6707075, DOI: 10.1017/ice.2018.40.Peer-Reviewed Original ResearchConceptsSurgical site infectionDisseminated cancerHealthcare-Associated InfectionsSSI ratesColorectal surgeryASA scoreSite infectionSSI riskColorectal proceduresRate of SSIRisk of SSIDevelopment of SSICommon healthcare-associated infectionsChronic obstructive pulmonary diseaseInfect Control Hosp EpidemiolBackgroundSurgical site infectionCurrent Procedural Technology codesPooled SSI rateNational Comprehensive Cancer Network (NCCN) member institutionsObstructive pulmonary diseaseClinical Modification codesLonger durationPotential risk factorsRisk-adjusted outcomesSurgical quality improvement
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply